Terence Ching is a clinical psychologist and associate research scientist in the Department of Psychiatry in the Yale School of Medicine. Terence co-leads psychedelic clinical trials as part of the Yale Program for Psychedelic Science, under the mentorship of Drs. Benjamin Kelmendi and Christopher Pittenger. He has interests and expertise in fear- and trauma-based disorders, integrative cognitive-behavior therapies, culturally attuned care, and therapeutic applications of psychedelics.Terence is also a MAPS-certified psychedelic therapist in the MDMA-Assisted Therapy for PTSD Expanded Access Program.

Science, Medicine, and Psychedelics

Emerging indications for psychedelic therapies

In the last fifteen years, psychedelics have been primarily investigated for treatment of depression, anxiety, and PTSD. More recently, research programs are exploring psychedelic therapies for other psychological and neurological disorders and illnesses, including obsessive compulsive disorder, Alzheimer’s disease, Lyme disease, adjustment disorder, and eating disorders. Join us to learn more about the new frontiers of clinical applications for psychedelics.